// App-Quantinova.ai

11572 : Correlation between local 18F-fluorodeoxyglucose PET/CT and T cell exhaustion for predicting treatment response in patients with advanced melanoma treated with checkpoint inhibitor mono-therapy.

Researchers

Presenter

  • Miguel Hernandez Pampaloni

Principal Investigators

  • Lorenzo Nardo

  • Alain Patrick Algazi

  • Katy K. Tsai

  • Kimberly Loo

  • Luca Facchetti

  • Susana Ortiz-Urda

  • Adil Daud

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • UCSF Department of Radiology and Biomedical Imaging, San Francisco, CA

  • UC San Francisco, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Melanoma

Biomarkers

  • 18F-fluorodeoxyglucose

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Cytotoxic T-lymphocyte-associated protein 4

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

  • Fludeoxyglucose (18F)

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final